OverviewChartNewsTraderScreen

BVT Discount Zert ROG 31.12.2024/  DE000VM04802  /

EUWAX
08/10/2024  08:47:37 Chg.+1.00 Bid22:00:35 Ask22:00:35 Underlying Strike price Expiration date Option type
222.92EUR +0.45% -
Bid Size: -		 -
Ask Size: -		 ROCHE GS - CHF 31/12/2024 Call
Newsfile Corp 17/09 Innovation Driving Cancer's Solid Tumors Market
GlobeNewswire 01/09 Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
TeleTrader 25/07 Europe lower premarket as earnings pour in
TeleTrader 25/07 Roche's H1 sales at 29.85 billion Swiss francs
GlobeNewswire 13/06 Pliant Therapeutics Announces Appointment of Steve Krognes to Board of Directors
GlobeNewswire 11/06 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
TeleTrader 27/05 Roche shuffles its executive committee
TeleTrader 16/05 Roche notes progress in obesity drug trial
TeleTrader 24/04 Roche's logs 14.4 billion Swiss francs in Q1 sales
TeleTrader 01/02 Roche's 2023 sales increase 1% to 58.7B Swiss francs
TeleTrader 04/12/2023 Roche to buy Carmot Therapeutics for $2.7B
TeleTrader 23/10/2023 Roche to buy Telavant for $7.1 billion
TeleTrader 27/07/2023 Roche's sales fall 8% ito 29.8B Swiss francs in H1
TeleTrader 26/04/2023 Roche posts sales of 15.3B Swiss francs in Q1
TeleTrader 02/02/2023 Roche's 2022 sales stable at 63.28B Swiss francs
TeleTrader 12/12/2022 Roche Pharmaceuticals CEO leaves the company
TeleTrader 18/10/2022 Roche's sales down 6% to 14.7B Swiss francs in Q3
TeleTrader 21/07/2022 Roche's H1 group sales up 5% to 32.3B Swiss francs
TeleTrader 25/04/2022 Roche's Q1 sales up 11% to $17.17 billion
TeleTrader 03/02/2022 Europe opens mixed with ECB's interest rates call in focus
TeleTrader 03/02/2022 Roche's 2021 sales up by 8% to 62.8B Swiss francs
TeleTrader 27/12/2021 Switzerland approves use of Roche COVID treatment
TeleTrader 04/11/2021 Novartis to sell stake in Roche for $20.7 billion
TeleTrader 09/09/2021 Roche acquires long-term biotech partner
TeleTrader 22/07/2021 Roche tops estimates with H1 sales at 30.71B Swiss francs